Literature DB >> 15276474

Myocyte hypertrophy and apoptosis: a balancing act.

Vanessa P M van Empel1, Leon J De Windt.   

Abstract

In response to a variety of extrinsic and intrinsic stimuli that impose increased biomechanical stress the heart responds by enlarging the individual myofibers. Even though myocardial hypertrophy can normalize wall tension, it instigates an unfavorable outcome and threatens affected patients with sudden death or progression to overt heart failure, suggesting that in most instances hypertrophy is a maladaptive process. Increasing evidence suggests that several of the signaling cascades controlling myocyte growth in the adult heart also function to enhance survival of the myocyte population in response to pleiotropic death stimuli. In this review, we summarize recent insights into hypertrophic signaling pathways and their ability to control the balance between myocyte life and death. As modulation of myocardial growth by antagonizing intracellular signaling pathways is increasingly recognized as a potentially auspicious approach to prevent and treat heart failure, the design of such therapies should respect the dichotomous action of pathways that dictate a balance between myocyte hypertrophy, survival and death. Copryright 2004 European Society of Cardiology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15276474     DOI: 10.1016/j.cardiores.2004.02.013

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  55 in total

1.  Vitamin D deficiency induces cardiac hypertrophy and inflammation in epicardial adipose tissue in hypercholesterolemic swine.

Authors:  Gaurav K Gupta; Tanupriya Agrawal; Michael G DelCore; Syed M Mohiuddin; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2012-04-17       Impact factor: 3.362

2.  The coordinated increased expression of biliverdin reductase and heme oxygenase-2 promotes cardiomyocyte survival: a reductase-based peptide counters β-adrenergic receptor ligand-mediated cardiac dysfunction.

Authors:  Bo Ding; Peter E M Gibbs; Paul S Brookes; Mahin D Maines
Journal:  FASEB J       Date:  2010-09-27       Impact factor: 5.191

Review 3.  Myocardial adaptations in the failing heart: cause or consequence?

Authors:  Sabine J van Dijk; Nazha Hamdani; Ger J M Stienen; Jolanda van der Velden
Journal:  J Muscle Res Cell Motil       Date:  2009-02-14       Impact factor: 2.698

4.  Cardiomyocyte p65 nuclear factor-κB is necessary for compensatory adaptation to pressure overload.

Authors:  Hadi Javan; Amanda M Szucsik; Ling Li; Christin L Schaaf; Mohamed E Salama; Craig H Selzman
Journal:  Circ Heart Fail       Date:  2014-12-05       Impact factor: 8.790

Review 5.  Regulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and aging.

Authors:  Vinodkumar B Pillai; Nagalingam R Sundaresan; Mahesh P Gupta
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

Review 6.  Cardiac fibroblast: the renaissance cell.

Authors:  Colby A Souders; Stephanie L K Bowers; Troy A Baudino
Journal:  Circ Res       Date:  2009-12-04       Impact factor: 17.367

7.  Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice.

Authors:  Iordanis Mourouzis; Erietta Kostakou; Georgios Galanopoulos; Polixeni Mantzouratou; Constantinos Pantos
Journal:  Mol Cell Biochem       Date:  2013-03-27       Impact factor: 3.396

8.  Positive transcription elongation factor b activity in compensatory myocardial hypertrophy is regulated by cardiac lineage protein-1.

Authors:  Jorge Espinoza-Derout; Michael Wagner; Louis Salciccioli; Jason M Lazar; Sikha Bhaduri; Eduardo Mascareno; Brahim Chaqour; M A Q Siddiqui
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

9.  Morphological and molecular changes of the myocardium after left ventricular mechanical support.

Authors:  Hideo A Baba; Jeremias Wohlschlaeger
Journal:  Curr Cardiol Rev       Date:  2008-08

10.  Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways.

Authors:  Benjamin E Reinking; Elesa W Wedemeyer; Robert M Weiss; Jeffrey L Segar; Thomas D Scholz
Journal:  Cardiovasc Diabetol       Date:  2009-07-31       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.